Peltz Stuart Walter 4
4 · PTC THERAPEUTICS, INC. · Filed Jan 9, 2023
Insider Transaction Report
Form 4
Peltz Stuart Walter
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-01-05+53,000→ 173,485 total - Award
Stock Option (Right to Buy)
2023-01-05+45,000→ 45,000 total(indirect: By Spouse)Exercise: $39.42Exp: 2033-01-04→ Common Stock (45,000 underlying) - Award
Common Stock
2023-01-05+18,000→ 56,830 total(indirect: By Spouse) - Award
Stock Option (Right to Buy)
2023-01-05+132,500→ 132,500 totalExercise: $39.42Exp: 2033-01-04→ Common Stock (132,500 underlying)
Footnotes (3)
- [F1]Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024.
- [F2]Includes 293 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2022 and 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022.
- [F3]This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.